Innovative drugs: From basic research to production
- Autores: Myasoedov N.F.1
-
Afiliações:
- Institute of Molecular Genetics
- Edição: Volume 86, Nº 3 (2016)
- Páginas: 151-157
- Seção: Scientific Session of the General Meeting of the Russian Academy of Sciences
- URL: https://journals.rcsi.science/1019-3316/article/view/178684
- DOI: https://doi.org/10.1134/S1019331616030084
- ID: 178684
Citar
Resumo
The results of studies of the molecular action mechanism of the peptides Semax and Selank—simple glyprolines that are used to prepare peptide-based drugs—are presented. A concept of creating an amino acid sequence of peptides is given; their interaction with receptor systems of the cell and their influence on the cell’s transcriptome, which forms the cell-mediated response, are considered. On the basis of the findings, pharmaceutical compositions of peptide drugs have been developed and their production and introduction into clinical practice have been organized.
Palavras-chave
Sobre autores
N. Myasoedov
Institute of Molecular Genetics
Autor responsável pela correspondência
Email: nfm@img.ras.ru
Rússia, Moscow
Arquivos suplementares
